01 Inability to afford expensive myeloma medication (Velcade) costing 300,000 AMD per vial for treatment

Inability to afford expensive myeloma medication (Velcade) costing 300,000 AMD per vial for treatment

Why is this interpretation wrong? Flag as wrong

Healthcare → Medicines and medical devices

• Parents · Low-income households · Benefit recipients · Patients — Socially vulnerable benefit recipient and mother of two minor children suffering from myeloma

Provision of or financial support for the expensive medication (Velcade) required for myeloma treatment

Direct assistance from the government to obtain the medicine

No location mentions.